Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
GenScript Launches Research-Grade Lentiviral Vector Packaging Service 2021-04-28 19:30
Samsung Biologics Reports First Quarter 2021 Financial Results 2021-04-28 16:37
New Distribution Facility Expands Bushu Pharma's Gateway to Asia (GTA) Services 2021-04-28 14:00
TCI Co., Ltd. becomes Asia's first biotechnology company whose climate ambitions are validated by SBTi 2021-04-27 15:53
Bushu Pharma's Collaboration with Suzuken Group Expands Services for Specialty Pharmaceuticals 2021-04-27 14:00
PharmAbcine to Present at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting 2021-04-26 20:00
I-Mab Announces Positive Topline Phase 2 Results for Olamkicept in Ulcerative Colitis 2021-04-26 19:00
Peijia Medical's TaurusOne® Transcatheter Aortic Valve Replacement System Approved for Commercialization 2021-04-25 08:53
Ronovo Surgical Completes Series A Financing, Aims to Transform Surgery with Innovations Focused on Simplicity, Precision and Intelligence. 2021-04-23 22:00
Jolly Good and Teijin Pharma Form a Partnership to Develop VR Digital Therapeutics for Depression 2021-04-23 21:00
JRSIS Health Care Corporation (OTCQX: JRSS) Announces Financial Results for the 2020 Fiscal Year 2021-04-23 02:00
Vaccines: More cooperation, less speculation 2021-04-22 21:00
Wuxi Strives to Build a World-class Biomedical Industry Chain 2021-04-22 19:06
PaperCut MF now Supports Enhanced Secure Scan to Fax for Healthcare 2021-04-22 17:27
ATH434 protects brain cells and improves motor function in Parkinsonian disorder 2021-04-21 20:11
111 to Announce First Quarter 2021 Unaudited Financial Results on May 19, 2021 - Conference Call to Follow 2021-04-21 20:00
Seed Health Closes $40 Million in Series A Financing to Launch New Categories, Accelerate Global Distribution and Expand Clinical Research 2021-04-21 20:00
Samsung Biologics Celebrates Its 10th Anniversary with Its Mission, "Driven. For Life." 2021-04-21 19:00
China Biologic Announces Completion of Going Private Transaction 2021-04-21 04:30
Transcenta Received IND Clearance from US FDA for Initiating Phase I Clinical Trial for its Bi-functional Anti-PD-L1/TGF-β Antibody TST005 2021-04-20 20:54
1 290 291 292 293 294 872